UNH vs CVS
UnitedHealth Group Incorporated vs CVS Health Corporation · Updated Jun 26, 2026
UNH — 11 winsCVS — 12 wins
Price Performance
UNH +37.31%CVS +53.60%
Performance
| UNH | CVS | |
|---|---|---|
| 1 Month | +10.13% | +15.09% |
| 3 Months | +53.68% | +44.67% |
| 6 Months | +26.76% | +33.26% |
| YTD | +25.72% | +31.58% |
| 1 Year | +38.03% | +54.51% |
| 3 Year | -12.67% | +18.19% |
| 5 Year | +33.12% | +80.53% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | +23.5% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
| CVS | +30.6% | +79.5% | -44.5% | -15.0% | -10.5% | +48.1% | -7.9% | +13.3% | -10.9% | -9.8% | -18.2% | +2.8% |
Valuation
| UNH | CVS | |
|---|---|---|
| P/E Ratio | 31.34 | 46.00 |
| Forward P/E | 9.99 | 13.26 |
| PEG Ratio | 2.08 | 3.25 |
| P/S Ratio | 0.82 | 0.32 |
| P/B Ratio | 3.55 | 1.67 |
| EV/EBITDA | 18.24 | 17.79 |
Financials
| UNH | CVS | |
|---|---|---|
| EPS (TTM) | $13.24 | $2.27 |
| Gross Margin | +22.74% | +15.56% |
| Operating Margin | +8.05% | +4.66% |
| Net Margin | +5.62% | +2.93% |
| ROE | +11.59% | +3.79% |
| ROA | +3.85% | +1.16% |
| Debt/Equity | 0.75 | 1.01 |
Growth
| UNH | CVS | |
|---|---|---|
| Revenue Growth YoY | +1.96% | +6.17% |
| Revenue Growth QoQ | -1.32% | -4.98% |
| EPS Growth YoY | +0.73% | +63.12% |
| EPS Growth QoQ | +62627.30% | 0.00% |
Technical
| UNH | CVS | |
|---|---|---|
| RSI (14) | 59.12 | 65.90 |
| % From 20-Day SMA | +3.87% | +7.15% |
| % From 50-Day SMA | +9.03% | +15.18% |
| % From 200-Day SMA | +23.65% | +29.21% |
| % From 52-Week High | -0.61% | -0.50% |
| % From 52-Week Low | +76.91% | +78.50% |
Analyst Ratings
UNH
Buy(36 analysts)
Strong SellHoldStrong Buy
Price Target
$425.81
+5.59% upside
CVS
Buy(22 analysts)
Strong SellHoldStrong Buy
Price Target
$103.64
+5.35% upside
Overview
| UNH | CVS | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $369.32B | $129.25B |
| Shares Outstanding | 908.1M | 1.28B |
| Avg Volume (10D) | 6.71M | 9.91M |
| Dividend Yield | 2.20% | 2.63% |
Frequently Asked Questions
Is UNH or CVS a better buy right now?
Based on 23 comparable metrics, CVS leads in 12 categories while UNH leads in 11. CVS has a consensus analyst rating with 22 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, UNH or CVS?
Over the past year, UNH returned +38.03% compared to CVS's +54.51%. In the short term (1 month), UNH returned +10.13% vs CVS's +15.09%.
Is UNH or CVS more expensive?
UNH trades at a P/E of 31.34 compared to CVS's 46.00. On a price-to-sales basis, UNH trades at 0.82x vs CVS's 0.32x. Forward P/E: UNH at 9.99 vs CVS at 13.26.
Which stock has higher growth, UNH or CVS?
UNH's revenue grew +1.96% year-over-year compared to CVS's +6.17%. EPS growth: UNH at +0.73% vs CVS at +63.12%.
Do UNH and CVS pay dividends?
UNH pays a dividend with a yield of 2.20%. CVS pays a dividend with a yield of 2.63%.
Which stock do analysts prefer, UNH or CVS?
UNH has 36 analysts with a target price of $425.81 (+5.59% upside). CVS has 22 analysts with a target of $103.64 (+5.35% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.